Teslexivir hydrochloride

• CAT Number: I042968
• CAS Number: 1075281-70-7
• Molecular Formula: C35H37BrClN3O4
• Molecular Weight: 679.04
• Purity: ≥95%
• Synonyms: 4-[2-[2-(4-benzylphenyl)-2-(2-methyl-6-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]-5-bromo-2-methoxybenzoic acid;hydrochloride
• InChI: InChI=1S/C35H36BrN3O4.ClH/c1-24-10-9-13-31(38-18-7-4-8-19-38)34(24)39(28-16-14-26(15-17-28)20-25-11-5-3-6-12-25)37-33(40)22-27-21-32(43-2)29(35(41)42)23-30(27)36;/h3,5-6,9-17,21,23H,4,7-8,18-20,22H2,1-2H3,(H,37,40)(H,41,42);1H
• InChIKey: PYDPVYMURKJIIO-UHFFFAOYSA-N
• SMILES: CC1=C(C(=CC=C1)N2CCCCC2)N(C3=CC=C(C=C3)CC4=CC=CC=C4)NC(=O)CC5=CC(=C(C=C5Br)C(=O)O)OC.Cl

Teslexivir hydrochloride（Cat No.:I042968）is an antiviral compound under investigation for its potential to treat viral infections. It works by inhibiting specific viral enzymes or processes essential for viral replication, making it effective against certain viral diseases. Teslexivir hydrochloride has shown promise in preclinical studies and clinical trials, particularly for treating infections caused by herpesviruses, such as herpes simplex virus (HSV). The compound is being studied for its ability to reduce viral load and prevent disease progression, offering a new potential therapeutic option in the field of antiviral drug development.